| TIF2, a 160 kDa transcriptional mediator for the ligand‐dependent activation function AF‐2 of nuclear receptors. JJ Voegel, MJ Heine, C Zechel, P Chambon, H Gronemeyer The EMBO journal 15 (14), 3667-3675, 1996 | 1316 | 1996 |
| The coactivator TIF2 contains three nuclear receptor‐binding motifs and mediates transactivation through CBP binding‐dependent and‐independent pathways JJ Voegel, MJS Heine, M Tini, V Vivat, P Chambon, H Gronemeyer The EMBO journal, 1998 | 609 | 1998 |
| Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH2-terminal domain B He, JA Kemppainen, JJ Voegel, H Gronemeyer, EM Wilson Journal of Biological Chemistry 274 (52), 37219-37225, 1999 | 467 | 1999 |
| Clinical, cellular, and molecular aspects in the pathophysiology of rosacea M Steinhoff, J Buddenkotte, J Aubert, M Sulk, P Novak, VD Schwab, ... Journal of Investigative Dermatology Symposium Proceedings 15 (1), 2-11, 2011 | 369 | 2011 |
| Neurovascular and neuroimmune aspects in the pathophysiology of rosacea VD Schwab, M Sulk, S Seeliger, P Nowak, J Aubert, C Mess, M Rivier, ... Journal of Investigative Dermatology Symposium Proceedings 15 (1), 53-62, 2011 | 322 | 2011 |
| Distribution and expression of non-neuronal transient receptor potential (TRPV) ion channels in rosacea M Sulk, S Seeliger, J Aubert, VD Schwab, F Cevikbas, M Rivier, P Nowak, ... Journal of investigative dermatology 132 (4), 1253-1262, 2012 | 269 | 2012 |
| A study on the epidemiology of rosacea in the UK J Spoendlin, JJ Voegel, SS Jick, CR Meier British journal of dermatology 167 (3), 598-605, 2012 | 265 | 2012 |
| Molecular and morphological characterization of inflammatory infiltrate in rosacea reveals activation of Th1/Th17 pathways T Buhl, M Sulk, P Nowak, J Buddenkotte, I McDonald, J Aubert, I Carlavan, ... Journal of Investigative Dermatology 135 (9), 2198-2208, 2015 | 263 | 2015 |
| IL-17/Th17 pathway is activated in acne lesions HL Kelhälä, R Palatsi, N Fyhrquist, S Lehtimäki, JP Väyrynen, ... PloS one 9 (8), e105238, 2014 | 193 | 2014 |
| Differential responses of PPARα, PPARδ, and PPARγ reporter cell lines to selective PPAR synthetic ligands M Seimandi, G Lemaire, A Pillon, A Perrin, I Carlavan, JJ Voegel, ... Analytical biochemistry 344 (1), 8-15, 2005 | 180 | 2005 |
| Transcriptional profiling shows altered expression of Wnt Pathway–and lipid Metabolism–Related genes as well as melanogenesis-related genes in melasma HY Kang, I Suzuki, DJ Lee, J Ha, P Reiniche, J Aubert, S Deret, D Zugaj, ... Journal of investigative dermatology 131 (8), 1692-1700, 2011 | 173 | 2011 |
| Transcriptional analysis of vitiligo skin reveals the alteration of WNT pathway: a promising target for repigmenting vitiligo patients C Regazzetti, F Joly, C Marty, M Rivier, B Mehul, P Reiniche, C Mounier, ... Journal of Investigative Dermatology 135 (12), 3105-3114, 2015 | 170 | 2015 |
| Genome-wide association study identifies three novel susceptibility loci for severe Acne vulgaris AA Navarini, MA Simpson, M Weale, J Knight, I Carlavan, P Reiniche, ... Nature communications 5 (1), 4020, 2014 | 101 | 2014 |
| Nonclinical and human pharmacology of the potent and selective topical retinoic acid receptor‐γ agonist trifarotene J Aubert, D Piwnica, B Bertino, S Blanchet‐Réthoré, I Carlavan, S Déret, ... British Journal of Dermatology 179 (2), 442-456, 2018 | 79 | 2018 |
| Pituitary adenylate cyclase activating polypeptide: an important vascular regulator in human skin in vivo S Seeliger, J Buddenkotte, A Schmidt-Choudhury, C Rosignoli, ... The American journal of pathology 177 (5), 2563-2575, 2010 | 77 | 2010 |
| Migraine, triptans, and the risk of developing rosacea: a population-based study within the United Kingdom J Spoendlin, JJ Voegel, SS Jick, CR Meier Journal of the American Academy of Dermatology 69 (3), 399-406, 2013 | 75 | 2013 |
| Nonstandard hydrogen bonding in duplex oligonucleotides. The base pair between an acceptor-donor-donor pyrimidine analog and a donor-acceptor-acceptor purine analog JJ Voegel, SA Benner Journal of the American Chemical Society 116 (15), 6929-6930, 1994 | 74 | 1994 |
| Redesigning nucleic acids SA Benner, TR Battersby, B Eschgfäller, D Hutter, JT Kodra, S Lutz, ... Pure and applied chemistry 70 (2), 263-266, 1998 | 60 | 1998 |
| Gene expression profiles in psoriasis: analysis of impact of body site location and clinical severity V Quekenborn‐Trinquet, P Fogel, O Aldana‐Jammayrac, P Ancian, ... British Journal of Dermatology 152 (3), 489-504, 2005 | 55 | 2005 |
| Topical ivermectin 10 mg/g and oral doxycycline 40 mg modified-release: current evidence on the complementary use of anti-inflammatory rosacea treatments M Steinhoff, M Vocanson, JJ Voegel, F Hacini-Rachinel, G Schäfer Advances in Therapy 33, 1481-1501, 2016 | 53 | 2016 |
